594.65 -5.40 (-0.90%)

79.84% Gain from 52W Low

189.6K NSE+BSE Volume

NSE 23 May, 2025 3:31 PM (IST)

Board Meeting
The board meeting for Healthcare Global Enterprises Ltd. is scheduled for today, for the purpose of Audited Results See details
MF Jan-2021 Dec-2020 Nov-2020
AUM (Rs Cr) AUM % Shares Held Month Change in Shares Month Change in Shares % Shares Held Month Change in Shares % Shares Held Month Change in Shares %
Tata Small Cap Fund Regular Growth 24.37 2.95% 1,602,000 0 0% 1,602,000 0% 1,602,000 0%
Tata India Pharma & Healthcare Fund Regular Growth 6.24 1.53% 410,000 0 0% 410,000 0% 410,000 0%
Sundaram Mid Cap Growth 45.80 0.80% 3,010,440 0 0% 3,010,440 0% 3,010,440 0%
Sundaram Diversified Equity Fund Growth 20.35 0.89% 1,337,642 0 0% 1,337,642 0% 1,337,642 0%
Sundaram Small Cap Fund - Regular Plan - Growth Option 14.10 1.22% 926,885 0 0% 926,885 0% 926,885 0%
Sundaram Services Regular Growth 9.93 0.80% 652,856 0 0% 652,856 0% 652,856 0%
Nippon India Pharma Fund - Growth 17.69 0.42% 1,162,723 0 0% 1,162,723 0% 1,162,723 10.95%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 20.98 1.04% 1,378,647 0 0% 1,378,647 0% 1,378,647 0.34%
ICICI Prudential Technology Fund Growth 4.97 0.35% 326,345 -59,257 -15.37% 385,602 1.17% - -%
Sundaram Long Term Tax Advantage Fund Series I Regular Growth 0.25 1.43% 16,375 -313 -1.88% 16,688 0% - -%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Regular Growth 0.65 1.79% 42,955 0 0% 42,955 0% - -%
Sundaram L/T Micro cap Tax Advantage Fund Sries III Regular Growth 1.92 2.71% 126,281 -2,527 -1.96% 128,808 0% - -%
Sundaram Long Term Tax Advantage Fund Series II Regular Growth 0.17 1.38% 11,000 -731 -6.23% 11,731 0% - -%
Sundaram Value Fund Series III Regular Growth - -% - - -% 22,000 0% - -%
Total: 11,004,149 -62,828 11,088,977 10,481,193